Tag: EP

Addressing Unjustified In-House Specifications During Routine Testing: A Practical Investigation Approach In the highly regulated pharmaceutical industry, maintaining the integrity of specifications set for raw materials is paramount. Unjustified in-house…

Addressing Non-Implementation of Pharmacopoeial Changes During Routine Testing In the pharmaceutical manufacturing and quality landscape, adhering to updated pharmacopoeial standards is crucial to ensure product safety and efficacy. A scenario…

Addressing Test Method Non-Compliance During Regulatory Inspections In the pharmaceutical manufacturing sector, ensuring compliance with analytical test methods is crucial to maintaining quality and regulatory standards. A scenario can arise…

Addressing Unjustified In-House Specifications during Inspections: A Compliance Gap Analysis The increasing complexity of pharmaceutical manufacturing processes often leads to instances of deviations or non-compliance, particularly concerning in-house specifications that…

Addressing Misuse of Reference Standards During Audit Reviews with CAPA Strategies The misuse of reference standards during audit reviews can introduce significant risks in pharmaceutical manufacturing, particularly impacting the integrity…

Addressing Deviation from Using Outdated Pharmacopoeial Monographs in Routine Testing In the complex landscape of pharmaceutical manufacturing, compliance to the latest pharmacopoeial monographs is critical for ensuring product quality and…

Analysis of Test Method Non-Compliance Risks Encountered During Inspections Test method non-compliance can be a significant challenge for pharmaceutical manufacturers, especially when undergoing regulatory inspections by authorities such as the…

Implementing Justification Strategies for In-House Specifications During Regulatory Submissions In the realm of pharmaceutical manufacturing, the challenge of justifying in-house specifications during submission support is a complex issue that can…

Understanding Test Method Non-Compliance During Supplier Qualification to Prevent Repeat Incidents In the realm of pharmaceutical manufacturing, non-compliance with testing methods during supplier qualification can lead to significant quality risks,…

Preventing Recurrences of Outdated Pharmacopoeial Monographs During Supplier Qualification In the pharmaceutical manufacturing landscape, the integrity of raw materials is paramount. Utilizing outdated pharmacopoeial monographs during the supplier qualification process…

Audit Review Challenges: Addressing Specification Harmonization Issues For pharmaceutical professionals, encountering discrepancies in specifications during audit reviews can be a significant challenge. Such deviations can compromise product quality, facilitate regulatory…

Investigating the Risks of Using Outdated Pharmacopoeial Monographs in Submission Support Pharmaceutical manufacturers often face significant compliance challenges, particularly when relying on outdated pharmacopoeial monographs during submission support. This issue…